HCA Healthcare, Inc. logo

HCA Healthcare, Inc.(HCA)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
3-STAR RATING
STRONG BUY
BUY for 53 days
PROFIT SINCE LAST BUY
+14.21% ▲
LAST CLOSE
$469.03
10/23/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for HCA

10/23/2026: HCA (3-star) is a STRONG-BUY. BUY for 53 days. Simulated Profits (14.21%). Updated daily EoD!

HCA Healthcare is a major U.S.-based operator of hospitals and outpatient facilities, known for its extensive geographic network and high market density. The company generates steady revenue through essential care services, bolstered by a strong focus on operational efficiency and scale. Its growth is primarily driven by expanding its footprint in outpatient settings and capturing demand from an aging population. However, investors should be mindful of risks related to regulatory changes in reimbursement, labor cost volatility, and increasing competition from retail-based care. The stock may suit value and dividend-focused investors seeking exposure to the stable, yet regulated, healthcare infrastructure sector.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe company leverages scale to drive consistent revenue and earnings growth in an essential industry.
Momentum investorMixed fitMomentum depends on current market sentiment toward healthcare spending and interest rate impacts on capital-intensive firms.
Value investorStrong fitHCA often trades at reasonable valuation multiples compared to its strong cash flow generation capabilities.
Dividend investorStrong fitThe company provides a reliable and growing dividend supported by stable, long-term healthcare demand.
Low-risk investorMixed fitWhile healthcare is defensive, the hospital sector carries significant regulatory and labor-related operational risks.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMediumHealthcare stocks often fluctuate based on shifts in U.S. health policy and payer reimbursement negotiations.
Valuation riskLowThe stock generally maintains a valuation tethered to stable cash flow expectations rather than speculative growth.
Competition risk (Outpatient/Retail)Medium / highNew entrants like retail pharmacies and technology-driven providers are disrupting traditional care delivery models.
Business qualityStrongHCA's high market density and scale create significant barriers to entry in its core markets.
Dividend incomeLowDividends are well-covered but yield is generally lower than traditional high-income sectors.
Execution riskMediumSuccess relies heavily on managing labor costs and maintaining effective physician recruitment across a large national footprint.

Price Behavior

Downtrend
PRICE PATH

Downtrend

The stock has experienced a sustained decline in price over recent periods.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit 77.48%
Avg. Invested days 62
Today’s Advisory Strong Buy
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
Stock Returns Performance Upturn Returns Performance icon 4.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 10/23/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
HCA receives a 4-star rating, supported by solid unit economics, solid company fundamentals, solid quantitative characteristics, and solid analyst coverage. The rating is constrained by weak price momentum, and limited analyst upside.

Company Fundamentals

★★★★★
HCA has solid overall fundamentals (4 stars), with solid financial health, solid growth momentum, and strong ownership. In FY2025 versus FY2024, solid earnings growth (+17.8%) and solid cash generation (FCF margin 10.2%) are partially offset by moderate revenue growth (+7.1%), soft profitability (net margin 9.0%).

Financial Health Rating

★★★★★
HCA's financial health is supported by strong cash strength, including free-cash-flow generation of $7.7B (10.2% of revenue). Liquidity is moderate (3 stars), which helps explain the 4-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is HCA's strongest growth driver at +36.4% FY2025 versus FY2024 (strong, 5 stars). By comparison, earnings growth (+17.8%, solid) is also solid, while revenue growth (+7.1%, moderate) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 78.7% and approximately 66.7% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 16.61% supports management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 6.01%
Vanguard Capital Management, LLC 4.68%
Sanders Capital, LLC 4.08%
State Street Corp 3.45%
Arnhold & S. Bleichroeder Advisers, LLC 3.04%

Unit Economics (Per $1K Revenue)

★★★★★
HCA generates approximately $415 of gross profit, $158 of operating income, and $102 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Moderate margins, cash conversion, and capital efficiency support the rating.

Economic Dimensions

★★★★★
Effective Tax Rate: 20.85%

Quantitative Style Profile

★★★★★
HCA has a high-quality, large-cap, liquid profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedQuality TiltLarge / Mega Cap StabilityHighly Liquid / Institution-Friendly

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 101.55B USD
Price to earnings Ratio 15.72
1Y Target Price 461.81
Price to earnings Ratio 15.72
1Y Target Price 461.81
Volume (30-day avg) 1.3M shares
Beta 1.11
52 Weeks Range 353.34 - 553.56
Updated Date 10/25/2026
52 Weeks Range 353.34 - 553.56
Updated Date 10/25/2026
Dividends yield (FY) 0.64%
Basic EPS (TTM) 29.83

How Company Makes Money

Business areaWhat it includesRetail investor read
Patient Care ServicesInpatient and outpatient medical services provided at hospitals and surgery centers.The company makes money when patients receive medical care that is paid for by insurance, government programs like Medicare/Medicaid, or out-of-pocket.
Geographic OperationsConcentrated hospital networks in high-growth U.S. states like Florida, Texas, and Tennessee.HCA targets states with growing populations and favorable economic conditions to ensure steady demand for its services.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Advertisement

Earnings Date

Report Date 2026-10-27
When Before Market
Estimate 6.74
Actual -

Profitability

Profit Margin 8.77%
Operating Margin (TTM) 15.16%

Management Effectiveness

Return on Assets (TTM) 12.29%
Return on Equity (TTM) 136.32%

Valuation

Trailing PE 15.72
Forward PE 13.85
Enterprise Value 145.39B
Price to Sales(TTM) 1.3
Enterprise Value 145.39B
Price to Sales(TTM) 1.3
Enterprise Value to Revenue 1.86
Enterprise Value to EBITDA 9.17
Shares Outstanding 216.50M
Shares Floating 144.32M
Shares Outstanding 216.50M
Shares Floating 144.32M
Percent Insiders 16.61
Percent Institutions 78.65

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.